| Quarterly Financials | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 1 | 6 | 5 | 5 | 5 | 5 | 7 |
| Expenses | 0 | 1 | 1 | 9 | 2 | 2 | 1 | 3 | 11 | 8 | 8 | 8 | 9 | 12 |
| EBITDA | -0 | -1 | -1 | -9 | -1 | -1 | -1 | -2 | -6 | -4 | -3 | -3 | -4 | -5 |
| Operating Profit % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % | -12,200 % | -96 % | -74 % | -50 % | -62 % | -82 % | -81 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 |
| Profit Before Tax | -0 | -1 | -1 | -9 | -1 | -1 | -1 | -2 | -7 | -4 | -4 | -4 | -5 | -7 |
| Tax | 0 | 0 | 0 | -2 | 0 | 0 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -2 |
| Net Profit | -0 | -1 | -1 | -6 | -1 | -1 | -1 | -1 | -6 | -3 | -3 | -3 | -5 | -5 |
| EPS in ₹ | 0.00 | -0.05 | -0.54 | -4.76 | -0.61 | -0.61 | -0.24 | -0.54 | -2.82 | -0.76 | -0.73 | -0.55 | -1.11 | -1.41 |
Pharmaids Pharmaceuticals
Pharmaids Pharmaceuticals
59.40
-0.06
(-0.10%)
Market Cap
209.70 Cr
EPS
-3.05
PE Ratio
-
Dividend Yield
0.00 %
Industry
Healthcare52 Week High
87.46
52 Week Low
31.90
PB Ratio
3.42
Debt to Equity
0.36
Sector
Pharmaceuticals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Company News
View All News
Pharmaids Pharmaceuticals Limited has reclassified 12 individuals from the Promoter/Promoter Group category to the Public category following the completion of an open offer by Dr. Shankarappa Nagaraja Vinaya Babu and Tumkur Trade Center Private Limited on September 23, 2025. The reclassified individuals collectively held 5.10% shareholding, with Sadhanala Venkata Rao being the largest at 4.32%. The reclassified promoters confirmed they do not hold more than 10% voting rights, do not exercise control over company affairs, have no special rights, and will not be represented on the Board for three years. Following the open offer completion, Dr. Shankarappa Nagaraja Vinaya Babu and Tumkur Trade Center Private Limited are now classified as the company's promoters. The company confirmed compliance with minimum public shareholding requirements and has no outstanding dues to regulatory authorities.
Pharmaids Pharmaceuticals Sells Entire 66.50% Stake in Anugraha Chemicals for Rs 6.65 Lakh
Sep 18, 2025
Sep 18, 2025Pharmaids Pharmaceuticals Limited completed the sale of its entire 66.50% partnership stake in Anugraha Chemicals to Mrs. Sneha Hadimani for Rs 6,65,000 on September 18, 2025. The divestment was approved by shareholders through postal ballot on August 14, 2025, and the Board of Directors on July 4, 2025. Following the transaction, Anugraha Chemicals ceased to be a material subsidiary of Pharmaids Pharmaceuticals. The company also executed a Termination Agreement to end the Investment Agreement dated January 25, 2023. Anugraha Chemicals contributed Rs 13,40,05,450 (68.91%) to consolidated revenue and Rs 3,74,15,092 (6.80%) to consolidated net worth as of March 31, 2025. The buyer is not related to the promoter group, and the transaction does not constitute a related party transaction. Additional amounts for loans, interest adjustments and other dues will be received separately.
Pharmaids Pharmaceuticals Limited completed the sale of three land parcels totaling approximately 13,975 square meters in Hirehalli Industrial Area, Tumkur District, Karnataka for Rs 19.56 crores. The buyer is Dr. S. N. Vinaya Babu, Chairman and Non-Executive & Non Independent Director of the company, making it a related party transaction conducted at arm's length. The sale was approved by shareholders through postal ballot on March 24, 2025, and the Board of Directors on February 12, 2025. The company entered into the sale deed on August 29, 2025, with completion on September 6, 2025. The company stated that no business operations are carried out on these land parcels, so the sale will not impact business operations. The buyer has made an open offer to public shareholders and will be classified as Promoter/Promoter Group upon completion of the open offer.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,636.20 | #1 3,82,526.00 | 34.22 | #1 54,729.00 | 9.71 | #1 10,980 | -19.84 | 43.29 | |
5,710.00 | 1,51,038.30 | 65.74 | 9,712.00 | 18.67 | 2,191 | 26.74 | 28.97 | |
3,567.10 | 1,21,948.70 | 59.71 | 11,539.40 | 6.99 | 1,911 | 19.91 | 51.91 | |
1,513.00 | 1,21,429.70 | 22.68 | 28,409.50 | 7.12 | 5,291 | 9.88 | 39.80 | |
1,244.70 | 1,02,131.70 | #1 18.31 | 33,741.20 | 16.73 | 5,725 | 1.26 | 34.86 | |
2,439.60 | 1,00,535.60 | 53.25 | 12,744.20 | #1 20.90 | 2,007 | -18.14 | 34.79 | |
991.15 | 98,802.10 | 21.41 | 23,511.00 | 18.55 | 4,615 | 2.60 | 40.31 | |
1,981.30 | 87,299.50 | 24.47 | 22,909.50 | 13.74 | 3,306 | #1 51.64 | 38.96 | |
5,459.50 | 64,864.00 | 28.71 | 13,458.30 | 3.70 | 2,216 | 21.39 | 52.88 | |
1,086.00 | 62,953.10 | 18.78 | 32,345.60 | 9.43 | 3,484 | -10.24 | 49.39 |
Forecast
Actual
Growth Rate
Revenue Growth
22.50 %
Net Income Growth
14.41 %
Cash Flow Change
-31.73 %
ROE
46.07 %
ROCE
-5.39 %
EBITDA Margin (Avg.)
-10.09 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 11 | 25 | 91 | 120 |
| Fixed Assets | 0 | 0 | 63 | 77 |
| Current Assets | 3 | 18 | 14 | 22 |
| Capital Work in Progress | 0 | 2 | 7 | 5 |
| Investments | 0 | 3 | 0 | 0 |
| Other Assets | 11 | 19 | 21 | 39 |
| Total Liabilities | 11 | 25 | 91 | 120 |
| Current Liabilities | 2 | 2 | 12 | 29 |
| Non Current Liabilities | 0 | 0 | 9 | 36 |
| Total Equity | 9 | 23 | 71 | 55 |
| Reserve & Surplus | -2 | 1 | 37 | 24 |
| Share Capital | 10 | 21 | 35 | 35 |
Cash Flow
| Cash Flow | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 12 | -8 | -3 |
| Investing Activities | 1 | -5 | -75 | -12 |
| Operating Activities | -0 | -4 | -11 | -14 |
| Financing Activities | 0 | 21 | 78 | 23 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Jan 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Apr 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 65.81 % | 65.80 % | 65.65 % | 55.56 % | 35.44 % | 20.70 % | 21.08 % | 16.54 % | 16.45 % | 9.95 % | 9.94 % | 9.70 % | 9.25 % | 5.64 % | 5.64 % | 5.56 % | 5.19 % | 5.22 % | 5.22 % | 5.14 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 33.44 % | 33.19 % | 33.70 % | 43.47 % | 63.98 % | 78.72 % | 74.07 % | 69.78 % | 69.87 % | 81.71 % | 81.27 % | 81.93 % | 60.78 % | 41.06 % | 41.06 % | 41.14 % | 41.03 % | 36.42 % | 36.59 % | 36.35 % |
| Others | 0.74 % | 1.01 % | 0.65 % | 0.97 % | 0.58 % | 0.57 % | 4.84 % | 13.68 % | 13.68 % | 8.34 % | 8.79 % | 8.37 % | 29.96 % | 53.30 % | 53.30 % | 53.29 % | 53.78 % | 58.37 % | 58.20 % | 58.51 % |
| No of Share Holders | 5,861 | 7,192 | 7,331 | 8,314 | 9,620 | 9,495 | 9,193 | 8,862 | 8,196 | 7,761 | 7,476 | 7,393 | 7,281 | 7,554 | 7,567 | 7,594 | 8,050 | 8,349 | 8,220 | 8,026 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 31 Dec 2022 |  Extraordinary General Meeting | NA | 31 Dec 2022 | 18.95 | 28.00 |
| 31 Jan 2024 | Extraordinary General Meeting | NA | 31 Jan 2024 | 62.10 | 61.02 |
| 25 Sept 2024 |  Annual General Meeting | NA | 25 Sept 2024 | 45.34 | 39.89 |
| 13 Nov 2024 |  Quarterly Result Announcement | NA | 13 Nov 2024 | 68.56 | 83.30 |
| 12 Feb 2025 | Quarterly Result Announcement | NA | 12 Feb 2025 | 73.59 | 68.30 |
| 23 May 2025 | Quarterly Result Announcement | NA | 23 May 2025 | 67.93 | 67.72 |
| 07 Aug 2025 | Quarterly Result Announcement | NA | 07 Aug 2025 | 63.22 | 63.49 |
| 21 Aug 2025 | Quarterly Result Announcement | NA | 21 Aug 2025 | 62.15 | 62.15 |
| 23 Sept 2025 | Annual General Meeting | NA | 23 Sept 2025 | 59.54 | 56.95 |
Announcements
Closure of Trading Window1 day ago
1 day agoAnnouncement under Regulation 30 (LODR)-Change in Management7 days ago
7 days agoShareholder Meeting / Postal Ballot-Scrutinizers Report7 days ago
7 days agoIntimation Under Regulation 31A(10)(Ii) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Reclassification Of Promoter(S) Pursuant To The Open Offer Under SEBI (SAST) Regulations 2011.7 days ago
7 days agoShareholder Meeting / Postal Ballot-Outcome of AGM9 days ago
9 days agoAnnouncement under Regulation 30 (LODR)-Diversification / DisinvestmentSep 18, 2025
Sep 18, 2025Announcement Under Regulation 30 - Intimation Of Registration Of Sale Deed.Sep 06, 2025
Sep 06, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 30, 2025
Aug 30, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 30, 2025
Aug 30, 2025Reg. 34 (1) Annual Report.Aug 29, 2025
Aug 29, 2025Notice Of Convening The 36Th Annual General MeetingAug 29, 2025
Aug 29, 2025Announcement under Regulation 30 (LODR)-Open Offer - UpdatesAug 29, 2025
Aug 29, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 29, 2025
Aug 29, 2025Post Offer AdvertisementAug 29, 2025
Aug 29, 2025Announcement Under Reg 30(LODR) - Appointment Of Secretarial AuditorAug 21, 2025
Aug 21, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On August 21 2025.Aug 21, 2025
Aug 21, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 21, 2025
Aug 21, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportAug 18, 2025
Aug 18, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 09, 2025
Aug 09, 2025Announcement under Regulation 30 (LODR)-Resignation of Chief Executive Officer (CEO)Aug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Change in ManagementAug 07, 2025
Aug 07, 2025Unaudited Financial Results For The Quarter Ended June 30 2025.Aug 07, 2025
Aug 07, 2025Board Meeting Outcome for Outcome Of The Board Meeting Dated August 07 2025.Aug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Open Offer - UpdatesAug 07, 2025
Aug 07, 2025Updates on Open OfferAug 07, 2025
Aug 07, 2025Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended 30Th June 2025.Aug 04, 2025
Aug 04, 2025Announcement under Regulation 30 (LODR)-Open Offer - UpdatesAug 01, 2025
Aug 01, 2025Updates on Open OfferAug 01, 2025
Aug 01, 2025Announcement under Regulation 30 (LODR)-Open Offer - UpdatesJul 30, 2025
Jul 30, 2025Announcement under Regulation 30 (LODR)-Open Offer - UpdatesJul 25, 2025
Jul 25, 2025Letter of OfferJul 25, 2025
Jul 25, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 16, 2025
Jul 16, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 15, 2025
Jul 15, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotJul 14, 2025
Jul 14, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 07, 2025
Jul 07, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJul 04, 2025
Jul 04, 2025Announcement under Regulation 30 (LODR)-Diversification / DisinvestmentJul 04, 2025
Jul 04, 2025Outcome Of The Board MeetingJul 04, 2025
Jul 04, 2025Closure of Trading WindowJun 30, 2025
Jun 30, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 24, 2025
May 24, 2025Submission Of Audited Financial Results Along With Auditors Report For The Quarter And Year Ended 31St March 2025May 23, 2025
May 23, 2025Board Meeting Outcome for Audited Financial Results For The Quarter And Year Ended March 31St 2025May 23, 2025
May 23, 2025Board Meeting Intimation for Consideration And Approval Of Audited Financial Results (Standalone And Consolidated) For The Quarter And Year Ended 31St March 2025.May 20, 2025
May 20, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 15, 2025
May 15, 2025Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 09, 2025
Apr 09, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 04, 2025
Apr 04, 2025Intimation Of Loan AgreementMar 28, 2025
Mar 28, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMar 26, 2025
Mar 26, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 26, 2025
Mar 26, 2025Closure of Trading WindowMar 25, 2025
Mar 25, 2025Technical Indicators
RSI(14)
Neutral 42.39
ATR(14)
Volatile 3.88
STOCH(9,6)
Neutral 60.92
STOCH RSI(14)
Neutral 67.37
MACD(12,26)
Bullish 0.23
ADX(14)
Weak Trend 21.96
UO(9)
Bearish 46.34
ROC(12)
Downtrend And Accelerating -1.86
WillR(14)
Neutral -68.73
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
